Eikon Therapeutics, Inc. Common Stock (EIKN) SEC Filings

Eikon Therapeutics, Inc. Common Stock (EIKN) SEC EDGAR filings (8-K, 10-Q, 10-K, S-1/A, S-1), newest first; latest 8-K filed 2026-08-14. Every filing links to the canonical SEC document. First-party data.

SEC filings — source: EDGAR
FiledFormTitle
2026-08-148-K8-K filed 2026-08-14 by Eikon Therapeutics, Inc.
2026-08-138-K8-K filed 2026-08-13 by Eikon Therapeutics, Inc.
2026-08-1310-Q10-Q filed 2026-08-13 by Eikon Therapeutics, Inc.
2026-08-038-K8-K filed 2026-08-03 by Eikon Therapeutics, Inc.
2026-06-108-K8-K filed 2026-06-10 by Eikon Therapeutics, Inc.
2026-06-018-K8-K filed 2026-06-01 by Eikon Therapeutics, Inc.
2026-05-118-K8-K filed 2026-05-11 by Eikon Therapeutics, Inc.
2026-05-1110-Q10-Q filed 2026-05-11 by Eikon Therapeutics, Inc.
2026-03-308-K8-K filed 2026-03-30 by Eikon Therapeutics, Inc.
2026-03-3010-K10-K filed 2026-03-30 by Eikon Therapeutics, Inc.
2026-02-068-K8-K filed 2026-02-06 by Eikon Therapeutics, Inc.
2026-01-28S-1/AS-1/A filed 2026-01-28 by Eikon Therapeutics, Inc.
2026-01-09S-1S-1 filed 2026-01-09 by Eikon Therapeutics, Inc.

EIKN overview · EIKN earnings · EIKN financials · EIKN KPIs · EIKN investor relations · EIKN ownership · EIKN peers

Data sourced from U.S. SEC EDGAR. Not personalized investment advice.